The insulin storage granule of the pancreatic beta cell is assembled within the trans Golgi network from around 50 or so gene products many of which are synthesized coordinately with the major component, proinsulin. An important contribution to our understanding of the regulation of this process has come from studies of the post-translational processing of proinsulin and of other proteins which are stored in the granule, particularly the processing enzymes themselves. The present review focusses on recent insights into the molecular nature of the processing machinery, and the granule Ca2+-dependent subtilisin-related endopeptidases which catalyse the initial rate-limiting step in the enzymic conversion of proinsulin. [Diabetologia (1994) 
The cellular biology of the regulated pathway of secretion
Formation of the insulin secretory granule is conventionally perceived as a singular vesiculation step occurring at the trans Golgi network (TGN) by which a condensed secretory product is enveloped in a simple phospholipid bilayer [1] [2] [3] [4] Figure 1 . Subsequent maturation is characterized by loss of the partial Fig. 1 . Secretory granule maturation and pathways of membrane traffic in the beta cell. The formation of dense core secretory granules in the cell (upper pathway) is preceded by condensation of the secretory product in the TGN and is often associated with membranes with a partial clathrin coat. Proteins not sorted at this stage appear to be secreted constitutively in smaller vesicles with electronlucent cores (lower pathway). The initial sorting event may be followed by granule-granule fusion and vesicular budding from the maturing granule. Such vesicles may serve as a mechanism of retrieval (A), disposal (B) of granule membrane components and contribute to a secondary constitutive release process (C) distinct from the major regulated exocytotic pathway (D). Membrane proteins associated with either regulated or constitutive exocytosis are presumably recycled (E) to the TGN or degraded clathrin coat of the granule membrane and further physical changes in the granule core which lead to the characteristic morphological features of the mature secretory granule [5] . The proteolytic conversion of proinsulin to insulin occurs during the maturation process and is initiated by changes in the ionic composition of the newly-formed "immature" or "nascent" granule [6, 7] . However it is evident that there are other changes occurring in the maturation process particularly at the level of the granule membrane [8, 9] . The existence of these events has been postulated on the basis of biochemical studies which show that the stoichiometry of insulin to C-peptide, which are released constitutively soon after granule formation, deviates from the theoretical 1:1 ratio expected. There is as yet no morphological correlate of this process, probably because the intermediate compartments involved are transitory and not easily distinguishable morphologically from immature granules and other vesicular structures (Fig. 1) . The types of maturation processes envisaged include a homotypic fusion of nascent granules, heterotypic fusion between nascent granules and other vesicular elements and retrieval of membrane and possibly granule contents through a clathrin-mediated process. Such processes could function as secondary sorting events, serve the purpose of salvaging granule membrane-associated components for re-use in the Golgi, or provide a means of redirecting granule constituents to lysosomes after they have fulfilled their function in the granule.
The initial sorting of the major granule lumenal proteins into the regulated pathway coincides with the formation of aggregates of secretory products in the TGN [3, 4] . Mutational analysis and transfection experiments indicate that the amino acid sequence of a sorted molecule is an important determinant of its entry into the regulated pathway [10, 11] but there is little clear evidence of a consensus sequence or sorting domain in proinsulin [12] [13] [14] [15] . The mechanism of sorting is generally conceived as either an association of the sorted protein with a membrane receptor [16, 17] or spontaneous self-association of the secreted product in response to changes in the TGN environment, in particular pH and Ca 2+ concentration [18] . Neither model of sorting, however, provides an adequate account of how proteins other than the quantitatively major constituents are packaged in the granule. It is clear that at least six other soluble proteins are co-packaged with insulin in the mature granule [19, 20] . Although most of these proteins are subject to translational control in the same way as proinsulin [21, 22] , it seems unlikely that their inclusion into the granule is simply the consequence of their presence in the TGN at the moment when proinsulin condenses. Indeed there is clear evidence that at least two proteins are actively sorted into the regulated pathway [23, 24] . It might be that the granule proteins have common physical properties which permit them to co-aggregate or interact with the TGN membrane. The fact that many have relatively acidic isoelectric points which correspond to the pH of the granule compartment and that they bind Ca ions may be important in this regard. A number of granule proteins also interact with membranes at acidic pH values, a phenomenon which might serve to promote sorting and which could be reversed after sorting by proteolytic cleavage of the molecules [24, 25] .
The movements of proteins which are intrinsic to the granule membrane proteins in the cell with a regulated secretory pathway are very poorly understood. Among these there are proteins which are rela- The wide tissue distribution, and Golgi localisation and neutral pH optimum of enzymes like furin indicate a ubiquitous function in the processing of membrane receptors and constitutively-secreted proteins in all cells. Other members by contrast show very specific tissue and cellular localisation and unique catalytic properties which are more consistent with specialised function and regulatory properties tively organelle-and tissue specific, e.g. dopamine hydroxylase in the chromaffin cell [26, 27] , those which are specific to secretory tissues but occur in a variety of organelles e.g. SCAMP proteins [28] , and those which are widely distributed in post-Golgi compartments of all cells such as the vacuolar proton translocator [29] . Two potential membrane markers have been identified in the insulin granule [30, 31] but at present little is known about their targetting to granule membranes or their movements during the process of granule formation, maturation and exocytosis. Their synthesis, like proinsulin, responds to stimulation of the cell with glucose, a hallmark of proteins of the granule lumen. This finding raises questions concerning the concept that the majority of granule membrane constituents recycle back to the TGN after exocytosis to be incorporated into nascent vesicles.
Post-translational processing at sites marked by basic amino acids
Post-translational proteolysis at sites marked by basic amino acids is ancient in evolutionary terms and appears to serve a similar physiological role in all eukaryotes in the activation of biological function of proteins (Tables i and 2 ). Other molecular, cellular and physiological functions are also affected by processing and roles can be envisaged also in folding, intracellular movement, sorting, and regulation of the solubility of the product. Polypeptide neurotransmitters and hormones which are secreted via the regulated secretory pathway in neuroendocrine tissues are generally processed at pairs of basic amino acids, typically Lys Arg and Arg Arg and much less frequently at Lys Lys or Arg Lys sites. Plasma membrane receptor molecules, viral glycoproteins and proteins which are secreted constitutively are usually processed at sites marked by a more complex array of basic amino acids, typically a dibasic site with a further basic amino acid in the P4, 5 or 6 position ( Table 2 ). The reaction sequence has been deduced from structural analysis of the products for a number of small peptides and is well illustrated by the pathway of proinsulin to insulin conversion (Fig. 2) which involves the action of two separate endopeptidases in conjunction with a carboxypeptidase H (E) (CPH) which removes the basic amino acids exposed at the C-termini after endoproteolytic cleavage. The endopeptidases of the insulin granule appear directed towards either Arg Arg or Lys Arg in the substrate although it should be pointed out that additional basic amino acids appear in the P4 position in the case of the B-C and C-A junction of a number of species. This arrangement is similar to the processing sites of constitutively secreted proteins and it seems likely that the presence of a basic amino acid in the P4 position iskinetically favourable though not essential in this case. An additional feature of the recognition of proinsulin by the endopeptidases is the secondary structure around the proinsulin processing sites. Proinsulin residues 19-31 and 53-66 are predicted to form /3-turns, and residues 46-54 and 69-76 to form omega loops. NMR data point to a close conformational relationship of the A and B chains in proinsulin to that in insulin and although the three dimensional structure of proinsulin is not documented a number of useful predictions can be made based upon molecular modelling (Fig. 3 ). Within this model it is notable that the two processing sites lie in close proximity and thus cleavage at one site may produce conformational changes around the other.
Enzymological studies of proinsulin endopeptidases
Two soluble, Ca2+-dependent, acidic endopeptidase activities capable of correctly processing human proinsulin in vitro to give insulin [32] have been identiffed. The activity designated type i cleaves exclusively on the C-terminal side of the Arg31 Arg32 sequence of proinsulin whereas the type 2 activity cleaves predominantly on the C-terminal side of the Lys64 Arg65 sequence (Fig. 2) . The two activities differ in their sensitivity to Ca 2+, with the type 1 halfmaximally activated at around 2.5 mmol/1 and the type 2 at 100 ~mol/1. The optimum pH for both type 1 and type 2 endopeptidase activity is 5.5 At pH 7.4 both enzymes show little activity and at pH values of 8.0 or above both enzymes are irreversibly inactivated. The pH profile and Ca 2+ responses of the two enzymes are thus consistent with their being active in the secretory granule and has led to the hypothesis that the ionic environment of the various compartments of the secretory pathway may be a key factor in regulating processing.
Studies with active site-directed tripeptide sulphonium salt inhibitors have shown that the precise sequence at the dibasic site is an important determinant of the specificity of these two endopeptidase ac- tivities [33] . Studies with mutant proinsulins in vitro and in vivo have confirmed the specificity of the two activities for dibasic sequences and have shown that the structural context of the cleavage site is crucial in determining whether or not it is subject to proteolysis [34] . That the conformation of the peptide backbone around the dibasic sites affects their susceptibility to proteolytic attack is further borne out by the finding that the type 2 activity preferentially cleaves the intermediate des-31, 32-proinsulin over intact proinsulin whereas the type 1 activity recognises the des-64, 65-proinsulin intermediate and proinsulin to a similar extent [35] . It has been argued [35] that this effectively results in sequential processing of proinsulin via the des-31, 32-proinsulin intermediate, however further kinetic data and cell biological studies are needed to support this conclusion.
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Molecular cloning of the proprotein endopeptidases
The key to the molecular cloning of the enzymes responsible for the endoproteolytic conversion of proinsulin came from genetic studies in conjugationdeficient yeast strains. These resulted in the cloning of a defective serine protease KEX2 [36] and were followed by the serendipitous discovery of a mammalian homologue, furin [37] , and the subsequent systematic search for other family members (Table 2 ; Fig. 4 ). The list of subtilisin-related protease family members is expanding and now includes at least nine distinct eukaryote genes together with a number of splice variants. The properties of the currently-documented members is outlined below. Furin is a Golgi-localised, Ca2+-dependent (K1/2 = 200 ~tmol/1), neutral (pH optimum 6.0-8.5) serine endoprotease of broad tissue distribution [38] . Cell transfection studies have shown that it recognises the consensus motif Arg X X Arg and is capable of processing a variety of proproteins including pro-von Willebrand factor [39] , mouse pro-fl-nerve growth factor [40] , complement pro-C3 and proalbumin [41] . Its processing-site specificity and proprotein substrate specificity indicate a role in the processing of proprotein precursors as they pass through the trans-Golgi, rather than in the conversion of prohormones and other peptides secreted by the regulated pathway. Nevertheless it is capable of converting the human proinsulin molecule at the B-chain/C-peptide (Lys Thr Arg Arg) but not the C-peptide/A-chain junction (Leu Gln Lys Arg) in vitro (Bailyes, Thomas and Hutton; personal communication). This raises the question of whether the actual levels of furin activity in the pancreatic beta cell are sufficient to contribute to insulin processing and whether its localisation overlaps with the compartment involved in sorting of the prohormone.
PC1 and PC2 [42, 43] , unlike furin, appear to be soluble proteins. There is no apparent transmembrane domain and the C-terminal domain is similar to that of furin and KEX2 only in as much as it is rich in acidic amino acids. However, both sequences contain a potential C-terminal amphipathic helical segment similar to the putative membrane anchor of carboxypeptidase H [44] . The subtilisin-related domains of PC1 and PC2 exhibit 45-65 % amino acid identity with other members of the subtilisin-related family and the Asp-His-Ser catalytic triad is placed in an equivalent position.
PC1 and PC2 mRNAs are associated with neuroendocrine tissues suggesting that they are likely candidates for endopeptidases associated with the regulated pathway of secretion. In situ hybridisation studies have demonstrated a distinct localisation of the PC1 and PC2 transcripts in pituitary and brain and it is clear in several endocrine tissues that the relative proportions of the enzymes vary. Such varia- Individual secretory granule proteins show marked differences in the response of their rates of bio_syr~thesis in islets to stimulation by glucose 16.7 mmol/1. Some (PC-I and CP-H) exit the endoplasmic reticulum more rapidly than insulin and are incorporated into nascent granules within 20 rain, whereas others (PC2) do not reach this destination until some 60 rain later. A consequence of these variations is that the protein composition of nascent granules is likely to vary according to the intensity and duration of the glycaemic stimulus tion is thought to account for region-specific differences of post-translational processing of proproteins which contain multiple bioactive sequences within their structure. Cell transfection studies have shown that PC1 and PC2 process proproteins such as POMC, proinsulin and prorenin at dibasic amino acid sites [45, 46] . The prorenin cleavage site mutant Arg Arg is cleaved but not the cleavage site mutants, Lys Lys, Arg Lys, Gln Arg, Arg Gln or Lys Arg Pro [47] . PC3 is also capable of cleaving mutant mouse prorenins in GH4C 1 cells at the monobasic Arg X X Arg site. The enzymes expressed in Xenopus oocytes show a dependence on millimolar concentrations of Ca 2+ ions and acidic pH (optimum 5.5) [48, 49] .
PC2 immunoreactivity is localised to insulin secretory granules and coincides with type 2 activity on ion-exchange chromatography of insulinoma secretory granule proteins [50] . The identity of PC2 with the type 2 activity is further supported by the ability of PC2 antisera to immunoprecipitate type 2 (but not type 1) activity from extracts of insulinoma secretory granules. Cell transfection studies show that PC2 selectively cleaves rat proinsulin I at the C-peptide/ A-chain (Lys Arg) junction while PC1 generates mature insulin but cleaves preferentially at the B-chain/ C-peptide (Arg Arg) junction [51] . This is consistent with them being the type 2 and type 1 proinsulin endopeptidases, respectively. The ability of PC1/type 1 to cleave at the C-peptide/A-chain junction in this study may be due to the presence of an Arg residue at the P4 position relative to the cleavage site (Arg Gln Lys Arg) in the rat proinsulin sequence compared to the human cleavage site (Leu Gln Lys Arg) (see article by Halban in this issue). PC4 is also soluble but restricted to the germ cells of the testis where it is developmentally regulated [53, 54] . The nature of its native substrate or cleavage specificity remains elusive. It is not able to cleave prorenin at its Lys Arg processing site or a prorenin mutant with an Arg X Lys Arg sequence in cell transfection studies.
PC5 demonstrates a ubiquitous pattern of tissue distribution similar to that of furin mRNA [55] with the highest levels being found in the adrenal cortex and gut with lower levels in many other peripheral tissues and tissues of the central nervous system. PC5 is an alternatively spliced form of PC6. PC6 itself is most abundant in the intestine but also present in many other tissues and cell lines. Its cleavage profile is similar to that of PC3 and it is conceivable that it plays a role in the processing of propeptides in enterochromaffin cells with substrates such as enteroglucagon.
Biosynthesis and post-translational processing of the proinsulin convertases
The structures of PC1 and PC2, indeed all the eukaryote subtilisin members, contain sites upstream of the conserved catalytic domain which bear a consensus motif for furin processing and are clearly cleaved at these sites during the process of intracellular maturation in Xenopus oocytes [48] , bovine adrenal [56] , anglerfish islets [57] and rat insulinoma tissue [48] .
PC2 is synthesised in isolated rat islets of Langerhans initially as 75kDa precursor which undergoes limited proteolytic processing to a 65kDa form by removal of an 84 amino acid prosequence at a site marked by the sequence Arg Lys Lys Arg 1~ [58, 59] . Other minor forms which are cleaved at an upstream Lys Arg Arg Arg 81 site and a downstream Arg Gly Tyr Arg 111 have also been found. The processing of proPC2 in rat islets (tla = 140 rain) (Fig. 5) is significantly slower than that of proinsulin (tl/2 = 40 min). By contrast PC1 is rapidly converted to an 80kDa protein by removal of the 83 amino acid prosegment presumably at a site marked by the sequence Arg Ser Lys Arg 11~ [43] . PC1 also undergoes C-terminal processing [60] with slower kinetics, possibly at one of several pairs of basic residues that occur in the molecule. The truncated 66kDa protein produced is the major form found in the islets of Langerhans. Both PC1 and PC2 are co-released with insulin in response to glucose and there is little evidence for se-$54 cretion via the constitutive pathway thus suggesting that they are efficiently sorted into the regulated pathway of secretion. The initial processing of PC2 and PC3 which probably occurs in the endoplasmic reticulum is possibly autocatalytic and perhaps intramolecular (see [61] ). The formation of the C-terminally truncated forms may, in contrast, occur after sorting to the secretory granule. At the present time it is not known if the pro-forms, intermediate forms and truncated forms of the enzymes have intrinsic activity, and if so, whether they differ in kinetic properties.
Insulin mRNA translation undergoes rapid and marked changes in the beta cell in response to ambient glucose concentrations (Fig. 5) . Chromogranin A and PC1 biosynthesis respond in a similar manner whereas PC2 and carboxypeptidase H usually change no more than a few fold [21, 62] . As a consequence the ratio of PC2 to proinsulin in nascent granules would be expected to vary with stimulus whereas PC1 to insulin would remain constant. The trend to relative depletion of PC2 would be further exacerbated by the fact that delivery of PC2 to the site of granule assembly in the TGN is delayed relative to that of proinsulin and PC1. This might result in a net decrease in the rate of conversion of proinsulin to insulin since PC2 will determine the flux through des 64, 65 proinsulin (Fig. 2) , and a relative increase in the concentration of des 31, 32 proinsulin at steady state during the conversion process. This in turn would be reflected in the composition of the insulin peptides secreted, since the newly-formed granules in which most of the processing occurs are competent for exocytosis. Such phenomena might account for the relative rise of proinsulin and des 31, 32 proinsulin with impaired glucose tolerance in humans (see article by Hales in this issue). There is a danger here however of oversimplification since there are many other factors which control the rate of processing and release of intermediates, including the relative size of the mature and nascent granule pool, the total islet tissue mass, the functional islet mass and the proportion of pancreatic beta cell in the population which are biosynthetically active (see article by Pipeleers in this issue).
